Overview
- FSSAI has sent formal notices to manufacturers and sellers named in coverage, including Dr Reddy’s, Nestle Health Science, Tirupati Wellness, M/s Nex International, M/s Shreyash Retail, Flipkart, Amazon Seller Services and Netmeds, asking them to explain the contested advertising.
- The inquiry targets product claims that promoted high‑protein support for preserving lean muscle during GLP‑1/GIP therapies and statements about muscle strength, immunity support and energy metabolism.
- The regulator said the product name and explicit references to GLP‑1/GIP therapies may create an improper association between a nutrition supplement and prescription drug treatments.
- Amazon has told regulators the product is no longer available on its marketplace and reiterated that third‑party sellers must follow Indian law and platform policies.
- FSSAI framed the notices as part of wider consumer‑protection enforcement, which could lead to stricter checks on how nutrition products are marketed online and clearer platform accountability for third‑party listings.